Clal Biotechnology Industries Ltd. 13D/13G Filings for Roth CH Acquisition IV Co. (ROCG)

Clal Biotechnology Industries Ltd. 13D and 13G filings for Roth CH Acquisition IV Co.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-06-02
5:12 pm
Purchase
2023-05-2313DRoth CH Acquisition IV Co.
ROCG
Clal Biotechnology Industries Ltd.4,584,422
7.880%
4,584,422increase
(New Position)
Filing